Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
Loreta A KondiliAlberto ZanettoMaria Giovanna QuarantaLuigina FerrignoValentina PanettaVincenza CalvarusoAnna Linda ZignegoMaurizia R BrunettoGiovanni RaimondoElisa BiliottiDonatella IeluzziAndrea IannoneSalvatore MadoniaLiliana ChemelloLuisa CavallettoCarmine CoppolaFilomena MoriscoFrancesco BarbaroAnna LicataAlessandro FedericoFederica CeriniMarcello PersicoMaurizio PompiliAlessia CiancioPiscaglia FabioLuchino ChessaAndrea GiacomettiPietro InvernizziGiuseppina BrancaccioAntonio BenedettiLeonardo BaiocchiIvan GentileNicola CoppolaGerardo NardoneAntonio CraxìFrancesco Paolo Russonull nullPublished in: United European gastroenterology journal (2023)
In patients with HCV-related cirrhosis, a more advanced liver disease and significant portal hypertension are independently associated with the de novo PVT risk after SVR.